Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Discovery
Cancer Discovery

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
    • Journal Press Releases
Research Watch: Colorectal Cancer

Germline DNA Polymerase Mutations Increase Cancer Susceptibility

DOI: 10.1158/2159-8290.CD-RW2013-006
  • Article
  • Info & Metrics
Loading

Abstract

Germline variants of POLD1 and POLE predispose to colorectal adenomas and carcinomas.

  • Major finding: Germline variants of POLD1 and POLE predispose to colorectal adenomas and carcinomas.

  • Concept: DNA polymerase δ and ε proofreading domain mutations impair correction of mispaired bases.

  • Impact: Individuals with an unexplained history of colorectal neoplasia may harbor POLE or POLD1 mutations.

Figure1

Germline mutations in at least 10 genes have been implicated in familial colorectal cancer predisposition syndromes, but some individuals with a family history of multiple benign colorectal adenomas or early-onset colorectal cancer do not have mutations in known cancer predisposition genes. To uncover additional risk variants, Palles and colleagues used linkage analysis to identify shared genomic regions among affected individuals within single families and searched for nonsilent coding variants within these regions. Analysis of one family identified a heterozygous germline mutation in POLE, which encodes the catalytic subunit of DNA polymerase ε, the enzyme responsible for synthesis and proofreading of the leading strand during DNA replication. This variant, which results in an amino acid substitution in the active site of the exonuclease domain that mediates proofreading, was identified in 12 additional unrelated individuals with a family history of colorectal tumors within a large validation set but was not identified in any control subjects. A similar analysis of another family identified a heterozygous mutation in POLD1 affecting the exonuclease domain of DNA polymerase δ, the enzyme that mediates lagging strand synthesis and proofreading. POLD1 mutation carriers were also prone to endometrial cancer, as is the case in patients with Lynch syndrome. The affected POLD1 and POLE residues are highly conserved, and the equivalent mutations led to a mutator phenotype in Schizosaccharomyces cerevisiae caused by increased base substitution arising from impaired exonuclease activity. Mapping of these mutations onto the structure of yeast DNA polymerase suggested that both likely induce detrimental exonuclease active site conformational changes. Consistent with these findings, POLD1- and POLE-mutant tumors were microsatellite stable but had an increased rate of base substitution mutations. POLD1 and POLE mutations should therefore be considered in patients with an unexplained history of multiple colorectal adenomas or early-onset cancers.

Palles C, Cazier JB, Howarth KM, Domingo E, Jones AM, Broderick P, et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet 2012 Dec 23 [Epub ahead of print].

  • ©2013 American Association for Cancer Research.
View Abstract
Next
Back to top

Published OnlineFirst January 10, 2013
doi: 10.1158/2159-8290.CD-RW2013-006

View this article with LENS

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Germline DNA Polymerase Mutations Increase Cancer Susceptibility
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
Citation Tools
Germline DNA Polymerase Mutations Increase Cancer Susceptibility
Cancer Discov January 10 2013 DOI: 10.1158/2159-8290.CD-RW2013-006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Germline DNA Polymerase Mutations Increase Cancer Susceptibility
Cancer Discov January 10 2013 DOI: 10.1158/2159-8290.CD-RW2013-006
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
  • Info & Metrics
Advertisement

Related Articles

Cited By...

  • Home
  • Alerts
  • Feedback
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement